Irina Rivkind Koffler analyst LIFESCI

Currently out of the existing stock ratings of Irina Rivkind Koffler, 14 are a BUY (48.28%), 9 are a HOLD (31.03%), 6 are a SELL (20.69%).

Irina Rivkind Koffler

Work Performance Price Targets & Ratings Chart

Analyst Irina Rivkind Koffler works at LIFESCI with a stock forecast success ratio of 65.12% fulfilled within 211.88 days on average.

Irina Rivkind Koffler’s has documented 514 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on MNK, Mallinckrodt plc at 06-Aug-2019.

Wall Street Analyst Irina Rivkind Koffler

Analyst best performing recommendations are on DRRX (DURECT).
The best stock recommendation documented was for EGRX (EAGLE PHARMACEUTICALS) at 1/9/2017. The price target of $64 was fulfilled within 2 days with a profit of $4.1 (6.02%) receiving and performance score of 30.1.

Average potential price target upside

DRRX Durect LGND Ligand Pharmaceuticals orporated EGRX Eagle Pharmaceuticals

Analyst name


Current price target

Potential Upside

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$3.7 (284.62%)


1 months 25 days ago

1/5 (20%)

$3.89 (350.45%)



9 months 16 days ago

0/2 (0%)

$27.7 (101.47%)



$24.51 (984.34%)


9 months 16 days ago

0/2 (0%)

$25.57 (661.71%)



$78.7 (6053.85%)

3 years 21 days ago

1/4 (25%)

$62.3 (351.98%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Irina Rivkind Koffler?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?